Published

Psilocybin: Chemical Foundations and Emerging Therapeutic Potential

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Mini-Reviews in Medicinal Chemistry
Date: 2026-06-01
Source: Crossref
DOI: 10.2174/0113895575429775260119043318
PubMed: 41879500

Authors

Patil Shivaputra A.Hunsberger Holly C.

Watch author

Derived topics and classifications

psilocybin psilocin Depression Addiction Neuroplasticity Pharmacology Receptor Pharmacology Longevity Clinical Trial Review Article Cancer Patients Treatment-Resistant Depression Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1080/17512433.2018.1415755 10.1038/s41386-022-01361-x 10.1016/j.neubiorev.2020.03.017 10.1310/hpj4806-473 10.1111/j.1749-6632.1957.tb40738.x 10.1124/pr.115.011478 10.1080/02791072.2019.1606472 10.1038/npp.2017.84 10.1503/cmaj.141358 10.3389/fnins.2018.00536 10.1021/acschemneuro.8b00043 10.1080/02791072.1997.10400185

Indexed papers citing this DOI

Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01

Related papers

Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.Oxidative medicine and cellular longevity · 2009-01-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17